We use the innovative power in combining material science and pharma,
revolutionizing drug delivery and giving patients a better and safer everyday life
We create new and innovative products with shorter time to market and mitigated risk.
We make this possible by combining material science & pharmaceutical development and by using established and approved active substances.
CEO Torbjörn W. Larsson presents the company on Aktiespararnas event Stora Aktiedagen in Stockholm.
Follow the presentation live online, via www.aktiespararna.se/tv/live.
Recieve press releases and reports via email.